Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 MicroRNAs of Epstein-Barr Virus Control Innate and Adaptive Antiviral Immunity.

Literature DB >> 28592533

MicroRNAs of Epstein-Barr Virus Control Innate and Adaptive Antiviral Immunity.

Manuel Albanese¹, Takanobu Tagawa¹, Alexander Buschle¹, Wolfgang Hammerschmidt².

Abstract

Epstein-Barr virus (EBV) has established lifelong infection in more than 90% of humanity. While infection is usually controlled by the immune system, the human host fails to completely eliminate the pathogen. Several herpesviral proteins are known to act as immunoevasins, preventing or reducing recognition of EBV-infected cells. Only recently were microRNAs of EBV identified to reduce immune recognition further. This Gem summarizes what we know about immunomodulatory microRNAs of herpesviruses.

Entities: Disease Species

Keywords: cancer; human herpesviruses; immune evasion; immune surveillance; microRNA

Mesh：

Substances：
MicroRNAs
RNA, Viral

Year: 2017 PMID： 28592533 PMCID： PMC5533892 DOI： 10.1128/JVI.01667-16

Source DB: PubMed Journal: J Virol ISSN： 0022-538X Impact factor: 5.103

44 in total

1. High-resolution profiling and analysis of viral and host small RNAs during human cytomegalovirus infection.

Authors: Thomas J Stark; Justin D Arnold; Deborah H Spector; Gene W Yeo
Journal: J Virol Date: 2011-10-19 Impact factor: 5.103

Review 2. MicroRNAs as mediators of viral evasion of the immune system.

Authors: Bryan R Cullen
Journal: Nat Immunol Date: 2013-02-15 Impact factor: 25.606

Review 3. MicroRNAs as regulatory elements in immune system logic.

Authors: Arnav Mehta; David Baltimore
Journal: Nat Rev Immunol Date: 2016-04-28 Impact factor: 53.106

4. Global profiling of viral and cellular non-coding RNAs in Epstein-Barr virus-induced lymphoblastoid cell lines and released exosome cargos.

Authors: Alessia Gallo; Serena Vella; Monica Miele; Francesca Timoneri; Mariangela Di Bella; Silvia Bosi; Marco Sciveres; Pier Giulio Conaldi
Journal: Cancer Lett Date: 2016-12-10 Impact factor: 8.679

5. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells.

Authors: Christopher S Sullivan; Adam T Grundhoff; Satvir Tevethia; James M Pipas; Don Ganem
Journal: Nature Date: 2005-06-02 Impact factor: 49.962

6. Epstein-Barr virus maintains lymphomas via its miRNAs.

Authors: D T Vereide; E Seto; Y-F Chiu; M Hayes; T Tagawa; A Grundhoff; W Hammerschmidt; B Sugden
Journal: Oncogene Date: 2013-03-18 Impact factor: 9.867

7. A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia.

Authors: Jin Qiu; Katherine Cosmopoulos; Michiel Pegtel; Erik Hopmans; Paul Murray; Jaap Middeldorp; Michael Shapiro; David A Thorley-Lawson
Journal: PLoS Pathog Date: 2011-08-25 Impact factor: 6.823

8. The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination.

Authors: Simon Jochum; Andreas Moosmann; Stephan Lang; Wolfgang Hammerschmidt; Reinhard Zeidler
Journal: PLoS Pathog Date: 2012-05-17 Impact factor: 6.823

9. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.

Authors: Rob J A Verhoeven; Shuang Tong; Gaohong Zhang; Jingfeng Zong; Yixin Chen; Dong-Yan Jin; Mei-Ru Chen; Jianji Pan; Honglin Chen
Journal: J Virol Date: 2016-06-24 Impact factor: 5.103

10. Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing.

Authors: Takanobu Tagawa; Manuel Albanese; Mickaël Bouvet; Andreas Moosmann; Josef Mautner; Vigo Heissmeyer; Christina Zielinski; Dominik Lutter; Jonathan Hoser; Maximilian Hastreiter; Mitch Hayes; Bill Sugden; Wolfgang Hammerschmidt
Journal: J Exp Med Date: 2016-09-12 Impact factor: 14.307

30 in total

1. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.

Authors: Eckart Meese; Friedrich A Grässer; Hiresh Ayoubian; Nicole Ludwig; Tobias Fehlmann; Jennifer Menegatti; Laura Gröger; Eleni Anastasiadou; Pankaj Trivedi; Andreas Keller
Journal: J Virol Date: 2019-01-17 Impact factor: 5.103

Review 2. Infection and immune control of human oncogenic γ-herpesviruses in humanized mice.

Authors: Donal McHugh; Nicole Caduff; Anita Murer; Christine Engelmann; Yun Deng; Hana Zdimerova; Kyra Zens; Obinna Chijioke; Christian Münz
Journal: Philos Trans R Soc Lond B Biol Sci Date: 2019-05-27 Impact factor: 6.237

3. Identification of aging-associated immunotypes and immune stability as indicators of post-vaccination immune activation.

Authors: Alper Cevirgel; Sudarshan A Shetty; Martijn Vos; Nening M Nanlohy; Lisa Beckers; Elske Bijvank; Nynke Rots; Josine van Beek; Anne-Marie Buisman; Debbie van Baarle
Journal: Aging Cell Date: 2022-09-08 Impact factor: 11.005

4. EBV protection- and susceptibility-related HLA alleles and EBV status in the Chinese population: A single-center study.

Authors: Dina Suolitiken; Yini Wang; Zhili Jin; Zhao Wang
Journal: Immun Inflamm Dis Date: 2022-07

9. Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the STK39 Gene in B Cells Infected by EBV.

Authors: Quentin Bazot; Kostas Paschos; Martin J Allday
Journal: J Virol Date: 2018-03-14 Impact factor: 5.103

10. Epstein-Barr Virus and the Human Leukocyte Antigen Complex.

Authors: Qingxue Li; Jeffrey I Cohen
Journal: Curr Clin Microbiol Rep Date: 2019-07-08